Last update 29 Aug 2025

ANOC-003

Overview

Basic Info

Drug Type
TCR-T Cell therapy
Synonyms-
Target
KRAS G12V
Action
inhibitors
Mechanism
KRAS G12V inhibitors(GTPase KRas G12V inhibitors)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease
Active Indication
Metastatic Pancreatic Ductal Adenocarcinoma
Inactive Indication-
Originator Organization
Anocca ABAnocca AB
Active Organization
Anocca ABAnocca AB
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with ANOC-003
NCT07145450
/ RecruitingPhase 1/2
Phase 1/2 Master Protocol for Open-Label, Multi-Centre, Single-Arm Sub-Studies, First in Human Clinical Studies of TCR-T Therapy (Autologous TCR- Modified T-Cell Therapy) Targeting Mutated Kirsten Rat Sarcoma (mutKRAS) Administered in Metastatic or Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Adult Patients With Specific mutKRAS and Human Leukocyte Antigen (HLA) Genotypes
100 Clinical Results associated with ANOC-003
Login to view more data
100 Translational Medicine associated with ANOC-003
Login to view more data
100 Patents (Medical) associated with ANOC-003
Login to view more data
100 Deals associated with ANOC-003
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic Pancreatic Ductal AdenocarcinomaPhase 2
Denmark
Anocca ABAnocca AB
03 Jul 2025
Metastatic Pancreatic Ductal AdenocarcinomaPhase 2
Germany
Anocca ABAnocca AB
03 Jul 2025
Metastatic Pancreatic Ductal AdenocarcinomaPhase 2
Netherlands
Anocca ABAnocca AB
03 Jul 2025
Metastatic Pancreatic Ductal AdenocarcinomaPhase 2
Sweden
Anocca ABAnocca AB
03 Jul 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free